Medical devices, healthcare technology and the business of care
510(k) clearance · K262470

Dual-Channel TENS & EMS Muscle Stimulator (Models TS1111, TS4111)

Changsha Anxiang Medical Technology Co., Ltd. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK262470

What did the FDA decide?

FDA recorded a substantial equivalence (SESE) decision on 2026-10-30 for K262470, a Dual-Channel TENS & EMS Muscle Stimulator submitted by Changsha Anxiang Medical Technology Co., Ltd. The device is listed under product code NGX in the Physical Medicine specialty, with models TS1111 and TS4111 named in the title. The record shows the application was received 07/17/2026.

SESE denotes 510(k) clearance rather than PMA approval, and the record does not identify a predicate device or summarize the basis for the equivalence finding. The source also does not describe the device's components, waveforms, output specifications, or labeled indications, so the scope of the cleared labeling remains unknown from this data. No clinical or performance conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Oct 30, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262470
Regulatory pathway
510(k) premarket notification
Product code
NGX
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, Muscle, Powered, For Muscle Conditioning.

Product code
NGX
FDA device class
2

FDA decision timeline

  1. K262470 received

    Application receipt date recorded by FDA.

  2. K262470 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NGX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Changsha Anxiang Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Changsha

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records